Principal Investigator
Timo Erkinjuntti
Contact: Susanna Melkas
Clinical Neurosciences, Neurology,
University of Helsinki and Helsinki University Hospital,
Finland.
susanna.melkas@hus.fi
Summary
Country | Finland |
---|---|
Principal Investigator | Timo Erkinjuntti |
Contact person (email) | Susanna Melkas (susanna.melkas@hus.fi) |
Key publication/reference | Pohjasvaara et al. Cerebrovasc Dis 2002;14:228-233 |
Years in which study conducted | 1993-1995 |
Sample | |
Size | 486 |
Population: Hospital/community | Hospital |
Selection: consecutive/random | Consecutive (3m after stroke) |
Admit with previous stroke? | Yes |
Admit with TIA? | Yes |
Age range | 55-85 |
Number of centres | 1 |
Control group: number, population, selection | None |
Assessment | |
Initial: Time and data collected/tests administered | Records: MedHx, lab tests, MRI, |
Detailed | 3m: VRF, neurological exam and clinical interview, function, psychiatric and NΨ |
Subsequent (follow-ups) | Survival 12.5 years later |
Stroke-related data | NIHSS, modified Rankin Scale, Orgogozo Scale, Scandinavian Stroke Scale |
Functional tests/data | Barthel Index, Schwab England and Blessed Functional Activity Scales, etc |
Other medical tests/data | Genotyping |
Neuropsychological tests | Test battery |
MRI scans, when and how many | Initial (n=396) |
PET scans | No |
Psychiatric exams/diagnoses | Dementia (CDR, Global Deterioration Scale), Beck Depression Scale, DSM-IV major depression |
Intervention trialled? | No |
CT=computed tomography scan, MedHx=medical history, VRF=vascular risk factors (hypertension, diabetes, atrial fibrillation, obesity, smoking etc.), NΨ=neuropsychological, TIA=transient ischemic attack, m=month, y=year